Persistence and resolution of suicidal ideation during treatment of depression in patients with significant suicidality at the beginning of treatment: The CRESCEND study

Ho Jun Seo, Young Eun Jung, Seunghee Jeong, Jung Bum Kim, Min-Soo Lee, Jae Min Kim, Hyeon Woo Yim, Tae Youn Jun

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background The appropriate length of time for patients who visit clinics with significant suicidal ideation to be closely monitored is a critical issue for clinicians. We evaluated the course of suicidal ideation and associated factors for persistent suicidality in patients who entered treatment for depression with significant suicidal ideation. Methods A total of 565 patients who had both moderate to severe depression (Hamilton Depression Rating Scale (HAMD) score ≥14) and significant suicidal ideation (Beck Scale for Suicide Ideation (SSI-B) score ≥6) were recruited from 18 hospitals in South Korea. Participants were assessed using the SSI-B, HAMD, Hamilton Anxiety Rating Scale, and Clinical Global Impression Scale-severity during a 12-week naturalistic treatment with antidepressant intervention. Participants were classified into resolved suicidality or persistent suicidality groups according to whether their suicidal ideation improved to SSI-B scores <6 and were sustained for 12 weeks. Results During the 12-week treatment, 206 (36.4%) patients were classified in the resolved suicidality group. Persistent suicidality was associated with intervention with SSRIs, higher SSI-B baseline score, and no HAMD or HAMA remission. The proportions of participants who had persistent suicidal ideation even with HAMD remission or response were 0.25 and 0.34, respectively. Limitations This study was observational, and the treatment modality was naturalistic. Conclusions A considerable number of patients had persistent suicidal ideation despite 12 weeks of antidepressant treatment. Close monitoring for suicidal ideation may be needed beyond the initial weeks of treatment and even after a response to antidepressants is observed.

Original languageEnglish
Pages (from-to)208-215
Number of pages8
JournalJournal of Affective Disorders
Volume155
Issue number1
DOIs
Publication statusPublished - 2014 Feb 1

Fingerprint

Suicidal Ideation
Depression
Antidepressive Agents
Therapeutics
Republic of Korea
Ambulatory Care
Suicide
Observational Studies
Anxiety

Keywords

  • Depression
  • Persistent suicidality
  • Predictive factor
  • Resolved suicidality
  • Suicide ideation

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Persistence and resolution of suicidal ideation during treatment of depression in patients with significant suicidality at the beginning of treatment : The CRESCEND study. / Seo, Ho Jun; Jung, Young Eun; Jeong, Seunghee; Kim, Jung Bum; Lee, Min-Soo; Kim, Jae Min; Yim, Hyeon Woo; Jun, Tae Youn.

In: Journal of Affective Disorders, Vol. 155, No. 1, 01.02.2014, p. 208-215.

Research output: Contribution to journalArticle

Seo, Ho Jun ; Jung, Young Eun ; Jeong, Seunghee ; Kim, Jung Bum ; Lee, Min-Soo ; Kim, Jae Min ; Yim, Hyeon Woo ; Jun, Tae Youn. / Persistence and resolution of suicidal ideation during treatment of depression in patients with significant suicidality at the beginning of treatment : The CRESCEND study. In: Journal of Affective Disorders. 2014 ; Vol. 155, No. 1. pp. 208-215.
@article{d513bf32e28e43e6b33211f296e427ba,
title = "Persistence and resolution of suicidal ideation during treatment of depression in patients with significant suicidality at the beginning of treatment: The CRESCEND study",
abstract = "Background The appropriate length of time for patients who visit clinics with significant suicidal ideation to be closely monitored is a critical issue for clinicians. We evaluated the course of suicidal ideation and associated factors for persistent suicidality in patients who entered treatment for depression with significant suicidal ideation. Methods A total of 565 patients who had both moderate to severe depression (Hamilton Depression Rating Scale (HAMD) score ≥14) and significant suicidal ideation (Beck Scale for Suicide Ideation (SSI-B) score ≥6) were recruited from 18 hospitals in South Korea. Participants were assessed using the SSI-B, HAMD, Hamilton Anxiety Rating Scale, and Clinical Global Impression Scale-severity during a 12-week naturalistic treatment with antidepressant intervention. Participants were classified into resolved suicidality or persistent suicidality groups according to whether their suicidal ideation improved to SSI-B scores <6 and were sustained for 12 weeks. Results During the 12-week treatment, 206 (36.4{\%}) patients were classified in the resolved suicidality group. Persistent suicidality was associated with intervention with SSRIs, higher SSI-B baseline score, and no HAMD or HAMA remission. The proportions of participants who had persistent suicidal ideation even with HAMD remission or response were 0.25 and 0.34, respectively. Limitations This study was observational, and the treatment modality was naturalistic. Conclusions A considerable number of patients had persistent suicidal ideation despite 12 weeks of antidepressant treatment. Close monitoring for suicidal ideation may be needed beyond the initial weeks of treatment and even after a response to antidepressants is observed.",
keywords = "Depression, Persistent suicidality, Predictive factor, Resolved suicidality, Suicide ideation",
author = "Seo, {Ho Jun} and Jung, {Young Eun} and Seunghee Jeong and Kim, {Jung Bum} and Min-Soo Lee and Kim, {Jae Min} and Yim, {Hyeon Woo} and Jun, {Tae Youn}",
year = "2014",
month = "2",
day = "1",
doi = "10.1016/j.jad.2013.11.002",
language = "English",
volume = "155",
pages = "208--215",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Persistence and resolution of suicidal ideation during treatment of depression in patients with significant suicidality at the beginning of treatment

T2 - The CRESCEND study

AU - Seo, Ho Jun

AU - Jung, Young Eun

AU - Jeong, Seunghee

AU - Kim, Jung Bum

AU - Lee, Min-Soo

AU - Kim, Jae Min

AU - Yim, Hyeon Woo

AU - Jun, Tae Youn

PY - 2014/2/1

Y1 - 2014/2/1

N2 - Background The appropriate length of time for patients who visit clinics with significant suicidal ideation to be closely monitored is a critical issue for clinicians. We evaluated the course of suicidal ideation and associated factors for persistent suicidality in patients who entered treatment for depression with significant suicidal ideation. Methods A total of 565 patients who had both moderate to severe depression (Hamilton Depression Rating Scale (HAMD) score ≥14) and significant suicidal ideation (Beck Scale for Suicide Ideation (SSI-B) score ≥6) were recruited from 18 hospitals in South Korea. Participants were assessed using the SSI-B, HAMD, Hamilton Anxiety Rating Scale, and Clinical Global Impression Scale-severity during a 12-week naturalistic treatment with antidepressant intervention. Participants were classified into resolved suicidality or persistent suicidality groups according to whether their suicidal ideation improved to SSI-B scores <6 and were sustained for 12 weeks. Results During the 12-week treatment, 206 (36.4%) patients were classified in the resolved suicidality group. Persistent suicidality was associated with intervention with SSRIs, higher SSI-B baseline score, and no HAMD or HAMA remission. The proportions of participants who had persistent suicidal ideation even with HAMD remission or response were 0.25 and 0.34, respectively. Limitations This study was observational, and the treatment modality was naturalistic. Conclusions A considerable number of patients had persistent suicidal ideation despite 12 weeks of antidepressant treatment. Close monitoring for suicidal ideation may be needed beyond the initial weeks of treatment and even after a response to antidepressants is observed.

AB - Background The appropriate length of time for patients who visit clinics with significant suicidal ideation to be closely monitored is a critical issue for clinicians. We evaluated the course of suicidal ideation and associated factors for persistent suicidality in patients who entered treatment for depression with significant suicidal ideation. Methods A total of 565 patients who had both moderate to severe depression (Hamilton Depression Rating Scale (HAMD) score ≥14) and significant suicidal ideation (Beck Scale for Suicide Ideation (SSI-B) score ≥6) were recruited from 18 hospitals in South Korea. Participants were assessed using the SSI-B, HAMD, Hamilton Anxiety Rating Scale, and Clinical Global Impression Scale-severity during a 12-week naturalistic treatment with antidepressant intervention. Participants were classified into resolved suicidality or persistent suicidality groups according to whether their suicidal ideation improved to SSI-B scores <6 and were sustained for 12 weeks. Results During the 12-week treatment, 206 (36.4%) patients were classified in the resolved suicidality group. Persistent suicidality was associated with intervention with SSRIs, higher SSI-B baseline score, and no HAMD or HAMA remission. The proportions of participants who had persistent suicidal ideation even with HAMD remission or response were 0.25 and 0.34, respectively. Limitations This study was observational, and the treatment modality was naturalistic. Conclusions A considerable number of patients had persistent suicidal ideation despite 12 weeks of antidepressant treatment. Close monitoring for suicidal ideation may be needed beyond the initial weeks of treatment and even after a response to antidepressants is observed.

KW - Depression

KW - Persistent suicidality

KW - Predictive factor

KW - Resolved suicidality

KW - Suicide ideation

UR - http://www.scopus.com/inward/record.url?scp=84891842285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891842285&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2013.11.002

DO - 10.1016/j.jad.2013.11.002

M3 - Article

C2 - 24262641

AN - SCOPUS:84891842285

VL - 155

SP - 208

EP - 215

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

IS - 1

ER -